GlassScriptPhysician profile
Jessica Stine
NPI 1720310089
$136,675.97
in general payments reported to CMS, 2019-2025
76 companies · $11K in 2025
The $11K reported for 2025 was more than what 91% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $9,780 · 2021: $39K · 2022: $9,367 · 2023: $34K · 2024: $23K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $41K · Consulting Fee: $11K · Food and Beverage: $7,276 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,779 · Travel and Lodging: $2,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $41,367.48 |
| Consulting Fee | $11,362.50 |
| Food and Beverage | $7,275.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,778.95 |
| Travel and Lodging | $2,254.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $66,544.54 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Baxter Healthcare | $59,471.94 | 2019-2025 | Floseal, Tisseel, Adept |
| Gen-Probe, INC. | $1,400.00 | 2019 | |
| Coopersurgical, INC. | $557.12 | 2019-2025 | Endosee, Advincula Delineator Uterine Manipulator |
| Merz North America, INC. | $546.89 | 2021-2023 | Xeomin |
| Janssen Biotech, INC. | $535.54 | 2021-2025 | Darzalex, Tecvayli, Rybrevant |
| Astrazeneca Pharmaceuticals LP | $471.70 | 2019-2025 | Imfinzi, Lynparza, Enhertu |
| Hologic Sales and Service, LLC | $470.08 | 2019-2025 | Coolseal Generator, Acessa Provu System, Myosure Tissue Removal Device |
| Merck Sharp & Dohme LLC | $443.89 | 2019-2025 | Keytruda, Lynparza |
| Abbvie INC. | $405.04 | 2019-2024 | |
| Astellas Pharma US INC | $324.52 | 2023-2025 | Veozah, Myrbetriq, Vyloy |
| Eisai INC. | $288.60 | 2019-2025 | |
| Seagen INC. | $277.73 | 2021-2025 | Tukysa, Tivdak |
| Gynesonics, INC. | $261.50 | 2019-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Clovis Oncology, INC. | $239.25 | 2019 |
Show all 76 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $238.26 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Therapeuticsmd, INC. | $232.65 | 2019 | |
| Glaxosmithkline, LLC. | $214.12 | 2020-2025 | Zejula, Jemperli |
| Ethicon US, LLC | $195.21 | 2019-2025 | Harmonic, Echelon Flex |
| Novartis Pharmaceuticals Corporation | $189.57 | 2022-2025 | |
| Incyte Corporation | $179.92 | 2023-2025 | Jakafi, Monjuvi, Zynyz |
| Conmed Corporation | $177.83 | 2022-2025 | Airseal, Visiclear |
| Tersera Therapeutics LLC | $173.18 | 2019-2025 | Zoladex |
| Daiichi Sankyo INC. | $162.08 | 2019-2025 | Enhertu, Datroway |
| Genentech USA, INC. | $159.22 | 2019-2025 | Polivy, Tecentriq, Tecentriq Hybreza |
| Celgene Corporation | $147.36 | 2023-2025 | Reblozyl |
| Takeda Pharmaceuticals U.S.A., INC. | $136.73 | 2022-2025 | Fruzaqla, Alunbrig |
| Regeneron Healthcare Solutions, INC. | $119.91 | 2021-2025 | Libtayo |
| Puma Biotechnology, INC. | $119.68 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $108.33 | 2021-2024 | Ultomiris |
| Myriad Genetic Laboratories, INC. | $104.22 | 2020-2023 | Myrisk |
| Kyowa Kirin, INC. | $90.57 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $89.59 | 2021-2024 | |
| Davol INC. | $89.18 | 2020 | |
| Genzyme Corporation | $85.78 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.33 | 2023-2025 | |
| Legend Biotech USA INC. | $82.43 | 2024-2025 | Carvykti |
| Array Biopharma INC | $78.95 | 2025 | Mektovi, Lorbrena, Braftovi |
| Sobi, INC | $66.51 | 2024-2025 | |
| Fennec Pharmaceuticals, INC. | $64.70 | 2024 | Pedmark |
| Pfizer INC. | $58.34 | 2021-2023 | |
| Emd Serono, INC. | $55.99 | 2023-2025 | Bavencio |
| Pharmacosmos Therapeutics INC. | $54.38 | 2023-2025 | Monoferric, Cosela |
| Exelixis INC. | $44.42 | 2023-2024 | Cabometyx |
| Taiho Oncology, INC. | $44.29 | 2023-2024 | |
| Lilly USA, LLC | $43.71 | 2024 | Retevmo, Jaypirca, Verzenio |
| Blueprint Medicines Corporation | $40.85 | 2021-2024 | Ayvakit |
| Sumitomo Pharma America, INC. | $39.30 | 2023-2024 | Myfembree |
| Morphosys, US INC. | $38.87 | 2022-2023 | Monjuvi |
| Pharmaessentia USA Corporation | $36.29 | 2024-2025 | Besremi |
| Hill-Rom Company, INC | $36.11 | 2021 | |
| Gilead Sciences, INC. | $33.50 | 2021-2025 | Trodelvy |
| Medtronic, INC. | $33.34 | 2023 | Intellis Adaptivestim |
| Recordati_rare_diseases_inc. | $31.67 | 2025 | Enjaymo |
| G1 Therapeutics, INC. | $30.59 | 2023 | Cosela |
| Amgen INC. | $30.42 | 2021-2023 | Nplate, Vectibix, Xgeva |
| Organogenesis INC. | $30.34 | 2024 | |
| Tempus Ai, INC | $29.94 | 2024 | Xt Cdx |
| Myovant Sciences INC. | $28.85 | 2022 | |
| Geron Corporation | $28.33 | 2025 | Rytelo |
| Bolder Surgical LLC | $27.64 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $27.27 | 2022-2024 | Onivyde, Somatuline Depot |
| Springworks Therapeutics, INC. | $24.58 | 2024 | Ogsiveo |
| Corcept Therapeutics | $22.25 | 2025 | Korlym |
| Allergan, INC. | $22.10 | 2020 | |
| Servier Pharmaceuticals LLC | $19.78 | 2025 | |
| Apellis Pharmaceuticals, INC. | $16.86 | 2023 | Empaveli |
| Adc Therapeutics America, INC. | $16.74 | 2022 | |
| Ge Healthcare | $15.73 | 2022 | |
| Aveo Pharmaceuticals, INC. | $15.72 | 2022 | |
| Rigel Pharmaceuticals, INC. | $14.13 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.11 | 2025 | Reblozyl |
| Janssen Pharmaceuticals, INC | $13.55 | 2023 | Xarelto |
| Meditrina | $11.86 | 2023 | |
| Tesaro, INC. | $11.43 | 2019 | |
| Adma Biomanufacturing LLC | $4.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Stine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.